Fig 1.
Diagrammatic representation of HER2 positivity rate in percentage in the periods of 2011–2012 (two years) and from October 2013 to October 2014 (12 months).
Table 1.
Concordance of test results in routine diagnostic HER2 assays in breast cancer.
Immunohistochemistry (IHC) and FISH in 2011 and 2012.
Table 2.
Concordance of test results in routine diagnostic HER2 assays in breast cancer.
Immunohistochemistry (IHC) and FISH between Oct 2013 and Oct 2014